Beyond a variety of physical barriers and limitations in the ability of a naïve or sensitized CD8+ T cell to “navigate” the TME stroma and ECM in the setting of cancer, stromal remodeling brings further limitations to cellular immunologic success. Here, CD8A is linked to cancer.